In this Pharmaceutical Executive video interview, Currax Pharmaceuticals, CEO, George Hampton, discusses why their drug isn’t experiencing the same supply issues as the bigger names in the space.
Maneuvering the Rapid Demand
You May Also Like
+ There are no comments
Add yours